Literature DB >> 2483691

Pathobiochemistry and early CT findings in acute pancreatitis.

B Hjelmqvist1, C Wattsgård, A Borgström, A Lasson, U Nyman, K Ohlsson.   

Abstract

Extrapancreatic findings at computed tomography (CT), performed within 24 h in 42 consecutive episodes of acute pancreatitis, were classified according to a scoring system (EP score) and were correlated to Ranson's prognostic signs, to duration of hospital stay, biochemical changes in plasma and pancreatic ischaemia found at CT with contrast enhancement. Increasing EP score was found to be related to increasing number of positive Ranson's signs, longer hospital stay and pancreatic ischaemia. Plasma levels of immunoreactive cationic trypsin and amylase were not proportional to EP score. alpha 1-protease inhibitor, antichymotrypsin but not immunoreactive pancreatic secretory trypsin inhibitor increased proportionally to EP score. No changes related to EP score were seen in alpha 2-macroglobulin levels. Serum levels of trypsin-alpha 1-protease inhibitor complex were maximal after 3 days and most pronounced in cases with high EP scores. Plasma levels of factor X, alpha 2-antiplasmin and C1-esterase inhibitor were found to be inversely proportional to EP score.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483691     DOI: 10.1159/000199910

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  2 in total

1.  Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.

Authors:  E Kemppainen; J Hedström; P Puolakkainen; J Halttunen; V Sainio; R Haapiainen; E Kivilaakso; U H Stenman
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

2.  Serum amylase and lipase concentrations and lipase/amylase ratio in assessment of etiology and severity of acute pancreatitis.

Authors:  R Pezzilli; P Billi; M Miglioli; L Gullo
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.